跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
G-43
首页
药物
G-43
G-43
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
PYRROLIDINE CARBOXYLIC ACID DERIVATIVES, PHARMACEUTICAL COMPOSITION AND METHODS FOR USE IN TREATING METABOLIC DISORDERS AS AGONISTS OF G-PROTEIN COUPLED RECEPTOR 43 (GPR43)
申请人: OGEDA SA
优先权: 2009
EP
US
6 件公开
COSMETIC COMPOSITION COMPRISING A MUCONOPEPTIDE
申请人: ACTIVEN
优先权: 2012
CN
EP
US
WO
5 件公开
STABILIZED POLYPEPTIDES
申请人: CYTIVA BIOPROCESS R & D AB
优先权: 2023
CN
EP
WO
4 件公开
INHIBITOR OF TDP-43 AGGREGATION
申请人: UNIV NAT CORP TOKYO MEDICAL & DENTAL
优先权: 2018
EP
US
WO
3 件公开
Method of increasing the quantity of colonic T regulatory cells via G-coupled protein receptor 43
申请人: HARVARD COLLEGE
优先权: 2014
US
2 件公开
Cosmetic composition comprising a muconopeptide
申请人: ACTIVEN
优先权: 2016
US
2 件公开
Active ingredient combinations comprising insecticidal and acaricidal properties
申请人: BAYER CROPSCIENCE AG
优先权: 2000
US
Anthracene derivatives and the use thereof for treating benign and malignant tumors
申请人: AETERNA ZENTARIS GMBH
优先权: 2006
EP
Ligand for G-protein coupled receptor GPR43 and uses thereof
申请人: EUROSCREEN SA
优先权: 2007
US
Compound preparation for promoting neuromuscular regeneration and preparation method thereof
申请人: HUASHAN HOSPITAL FUDAN UNIV
优先权: 2009
CN
第 1 / 8 页
上一页
下一页
药物
反馈